Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
200 hedge funds and large institutions have $589M invested in Immunogen Inc in 2018 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 65 increasing their positions, 56 reducing their positions, and 45 closing their positions.
434% more call options, than puts
Call options by funds: $18.7M | Put options by funds: $3.49M
16% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 56
4% less funds holding
Funds holding: 208 → 200 (-8)
16% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 45
50% less capital invested
Capital invested by funds: $1.18B → $589M (-$592M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$21.6M |
| 2 |
Morgan Stanley
New York
|
+$15.5M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$10.2M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.52M |
| 5 |
Two Sigma Investments
New York
|
+$6.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$67.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.3M |
| 3 |
O
OrbiMed
New York
|
-$13.9M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$8.64M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.49M |
IMGN Hedge Fund Activity: Q4 2018 in Review
200 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2018, worth a combined $589M — down 50% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of IMGN and 38 opened new positions — a net loss of 7 holders — while 56 trimmed existing stakes and 65 added.
The largest buyer was Millennium Management, adding an estimated $21.6M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $67.2M sold.
- 200 institutional investors held Immunogen Inc (IMGN) as of Q4 2018, down from 208 in Q3 2018.
- Funds reported $589M of Immunogen Inc stock for Q4 2018, down 50% quarter-over-quarter.
- 38 funds opened new Immunogen Inc positions in Q4 2018 and 45 closed out, a net change of -7 holders.
- The largest Immunogen Inc buyer in Q4 2018 was Millennium Management, an estimated $21.6M added.
- The largest Immunogen Inc seller in Q4 2018 was Capital Research Global Investors, an estimated $67.2M sold.
Based on aggregated 13F filings for Q4 2018.